Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only identifies disease-causing genetic mutations but also predicts the type of ...
Vanda Pharmaceuticals Inc. (Vanda) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for imsidolimab, a novel IgG4 IL-36 receptor ...
FDA confirmed that data from single-arm studies in rare diseases, such as in ultra-rare deadly pediatric cancer osteosarcoma, ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed a novel artificial intelligence tool that not only ...
Research by University of Sydney scientists has uncovered a mechanism that may explain why glioblastoma returns after ...
Mount Sinai scientists developed V2P, a powerful new AI tool that predicts how specific DNA mutations translate into disease, ...
On April 28, 2022, at a highly anticipated concert in Spokane, Washington, the musician Paul McCartney astonished his audience with a groundbreaking application of AI: He began to perform with a ...
The Food and Drug Administration rolled out a rapid-fire series of moves this month that could reshape how Americans manage ...
Researchers at Karolinska Institutet and KTH have developed a computational method that can reveal how cells change and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback